Home
Ra Capital Management, 10% Owner: AN2 Therapeutics ANTX Buy · Filed 23/08/22
Trade details
- Type
- Insider buy
- Amount
- $16,000,002
- Shares · price
- 1,777,778 sh · $9.00 a share
- Held after
- 5,135,683 sh
- Trade date
- 23/08/18
- Filed
- 23/08/22
- Days to filing
- 4 days
5 insiders bought this week
- Insiders buying this week
- 5 insiders
- Holding change
- +52.9%
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 23/07/19~23/09/17Ra Capital Management's recent trades
- Ra Capital Management
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
- Ra Capital Management
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
- Ra Capital Management
SellWerewolf Therapeutics
SellWerewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
- Ra Capital Management
SellWerewolf Therapeutics
SellWerewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
- Ra Capital Management
BuyHemab Therapeutics Holdings
BuyHemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16
